Francis J. T. Fildes
Directeur/Bestuurslid bij ProSkelia SAS
Actieve functies van Francis J. T. Fildes
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ProSkelia SAS
ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million. | Directeur/Bestuurslid | - | - |
Loopbaan van Francis J. T. Fildes
Eerdere bekende functies van Francis J. T. Fildes
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AVADEL PHARMACEUTICALS PLC | Directeur/Bestuurslid | - | 02-05-2018 |
Fildes Partners Ltd. | Directeur/Bestuurslid | 22-07-2010 | - |
Algemeen Directeur | 01-09-2002 | - | |
ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2002 | 01-12-2002 |
KERYX BIOPHARMACEUTICALS | Directeur/Bestuurslid | - | - |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Directeur/Bestuurslid | - | - |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Directeur/Bestuurslid | 08-09-2009 | - |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Directeur/Bestuurslid | 01-01-2008 | - |
Independent Dir/Board Member | 01-01-2008 | - | |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Directeur/Bestuurslid | - | - |
Opleiding van Francis J. T. Fildes
The University of Liverpool | Undergraduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 6 |
Frankrijk | 4 |
Ierland | 2 |
Operationeel
Director/Board Member | 8 |
Undergraduate Degree | 1 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 7 |
Commercial Services | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
AVADEL PHARMACEUTICALS PLC | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Commercial Services |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
Fildes Partners Ltd. | |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Health Technology |
ProSkelia SAS
ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million. | Commercial Services |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |